BNTC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Benitec Biopharma Inc (BNTC) is not a strong buy at this moment for a beginner investor with a long-term focus. While hedge funds are significantly increasing their positions, the lack of strong financial performance, no recent positive news, and bearish technical indicators suggest that holding off on buying is prudent until more favorable conditions arise.
The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 53.973, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (10.715) with resistance at 11.28 and support at 10.15. Overall, the technical indicators do not strongly support a buy signal.
Hedge funds are significantly increasing their positions, with a 599.83% increase in buying over the last quarter. The stock has an 80% chance to gain 17.86% in the next month based on similar candlestick patterns.
No significant insider trading trends. No recent news or event-driven catalysts. The financials show no revenue growth, and the company remains unprofitable with a net income of -$11.84M in Q2 2026.
In Q2 2026, the company reported no revenue growth (0% YoY), a net income of -$11.84M (up 23.92% YoY), and an EPS of -0.26 (unchanged YoY). Gross margin remains at 0%. The financials indicate no significant growth or profitability improvements.
No recent analyst ratings or price target changes available.
